Results 61 to 70 of about 994 (126)

Human papillomavirus vaccination coverage in Northeast Brazil, 2013-2021: a descriptive study. [PDF]

Epidemiol Serv Saude, 2023
Glehn MPV, Nascimento LMD, Freire KMR, Minuzzi TTCES, Hott CE, Maranhão AGK, Moraes C.   +6 more
europepmc   +1 more source

Systematic literature review of primary and secondary cervical cancer prevention programs in South America. [PDF]

Rev Panam Salud Publica, 2023
Gomes MLS, Moura NDS, Magalhães LC, da Silva RR, Silva BGS, Rodrigues IR, Sales LBF, Oriá MOB.   +7 more
europepmc   +1 more source

Eventos adversos pós-vacina contra o papilomavírus humano em adolescentes: revisão sistemática da literatura [PDF]

Objective: The objective of this study was to investigate the occurrence of Events Supposedly Attributable to Vaccination and/or Immunization associated with the Human Papillomavirus vaccine among adolescents of both sexes.
Carvalho, Natatia Santana, Duarte, Camila Kümmel, Faria, Ana Paula Vieira, Luvisaro, Bianca Maria Oliveira, Matozinhos, Fernanda Penido, Satil Neto, Adalton Elérito, Silva, Thales Philipe Rodrigues da, Silva, Tércia Moreira Ribeiro da   +7 more
core   +1 more source

Evaluation of therapeutic potency of human papillomavirus-16 E7 DNA vaccine alone and with interleukin-18 as a genetic adjuvant [PDF]

, 2018
AIMS: Despite the existence of effective preventive vaccines for human papillomavirus (HPV), therapeutic vaccines that trigger cell-mediated immune responses are required to treat established infections and malignancies.
Azadmanesh, Kayhan, Fazeli, Maryam, Ghaemi, Amir, Mahmoodi, Mahmood, Mirshafiey, Abbas, Pourhossein, Behzad, Shahmahmoodi, Shohreh   +6 more
core   +1 more source

Effect of educational intervention for compliance of school adolescents with the human papillomavirus vaccine. [PDF]

Rev Esc Enferm USP, 2022
Ferreira HLOC, Siqueira CM, Sousa LB, Nicolau AIO, Lima TM, Aquino PS, Pinheiro AKB.   +6 more
europepmc   +1 more source

PAPILOMAVÍRUS HUMANO: UMA ABORDAGEM ATUAL [PDF]

, 2017
O desenvolvimento do câncer cervical e sua associação ao papilomavírus humano (HPV) estão fortemente evidenciados em estudos epidemiológicos, sendo o HPV o principal fator para a doença.
ENTIAUSPE, LUDMILA, GONÇALVES, CARLA VITOLA, MARTINEZ, ANA MARIA BARRAL DE, MENDOZA-SASSI, RAÚL ANDRÉS   +3 more
core   +2 more sources

Adverse events following immunization in pregnant women from Minas Gerais. [PDF]

Rev Saude Publica, 2021
Silveira IOD, Silva TPRD, Luvisaro BMO, Silva RBD, Gusmão JD, Vimieiro AM, Oliveira VC, Souza KCR, Faria APV, Matozinhos FP.   +9 more
europepmc   +1 more source

Vacinação pública contra o Papilomavirus Humano no Brasil [PDF]

, 2018
Human papillomavirus (HPV) infection is associated with several cutaneomucous lesions, such as cervical cancer, vagina, vulva, anus, larynx, oropharynx and genital warts, and invasive cervical carcinoma is its main outcome.
Santos, José Gilmar Costa
core  

Vaccination coverage against human papillomavirus (HPV) and associated factors in female academics from a university in southwestern Goiás, Brazil. [PDF]

Rev Saude Publica, 2021
Oliveira PS, Gonçalves CV, Watte G, Costa JSDD.   +3 more
europepmc   +1 more source

Prevalência de HPV na saliva da população da clínica dentária universitária da UCP-Viseu [PDF]

, 2012
Introdução: Os vírus do papiloma humano (HPV) são uma família de vírus de DNA não envelopados associados principalmente ao cancro do colo do útero. Contudo, há dados epidemiológicos que sugerem que o HPV desempenha um papel importante como fator de risco
Galo, Alexandra de Almeida
core